Akila Sasantha Weerasekera, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Diseases | 1 | 2023 | 592 | 0.570 |
Why?
|
Low Back Pain | 1 | 2023 | 956 | 0.500 |
Why?
|
Aspartic Acid | 3 | 2024 | 576 | 0.410 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1222 | 0.380 |
Why?
|
Choline | 2 | 2023 | 493 | 0.380 |
Why?
|
Creatine | 2 | 2023 | 421 | 0.370 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1458 | 0.360 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2020 | 1414 | 0.350 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2023 | 3760 | 0.350 |
Why?
|
Nucleus Accumbens | 2 | 2022 | 366 | 0.310 |
Why?
|
Central Nervous System Depressants | 2 | 2018 | 167 | 0.290 |
Why?
|
Glutamic Acid | 4 | 2024 | 1169 | 0.280 |
Why?
|
Schizophrenia | 1 | 2024 | 6882 | 0.260 |
Why?
|
Inositol | 2 | 2024 | 218 | 0.240 |
Why?
|
Glutamine | 2 | 2017 | 578 | 0.240 |
Why?
|
Caudate Nucleus | 2 | 2022 | 393 | 0.230 |
Why?
|
Thalamus | 3 | 2023 | 1023 | 0.210 |
Why?
|
Gangliosidoses, GM2 | 1 | 2021 | 17 | 0.200 |
Why?
|
Ethanol | 2 | 2018 | 1342 | 0.200 |
Why?
|
Trehalose | 1 | 2020 | 88 | 0.190 |
Why?
|
Meningitis, Cryptococcal | 1 | 2020 | 63 | 0.180 |
Why?
|
Nitriles | 4 | 2018 | 956 | 0.180 |
Why?
|
Brain | 4 | 2022 | 26385 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2021 | 454 | 0.170 |
Why?
|
Ferritins | 1 | 2021 | 590 | 0.160 |
Why?
|
Hippocampus | 3 | 2024 | 3675 | 0.160 |
Why?
|
Gyrus Cinguli | 1 | 2024 | 1091 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 528 | 0.150 |
Why?
|
Oxidopamine | 1 | 2017 | 169 | 0.150 |
Why?
|
Dyskinesias | 1 | 2017 | 78 | 0.150 |
Why?
|
Levodopa | 1 | 2017 | 219 | 0.140 |
Why?
|
Fibromyalgia | 1 | 2021 | 388 | 0.140 |
Why?
|
Positron-Emission Tomography | 5 | 2020 | 6234 | 0.140 |
Why?
|
Putamen | 1 | 2017 | 291 | 0.140 |
Why?
|
Long-Term Potentiation | 1 | 2018 | 293 | 0.140 |
Why?
|
Quinolines | 1 | 2021 | 732 | 0.130 |
Why?
|
Exploratory Behavior | 1 | 2016 | 270 | 0.130 |
Why?
|
Cocaine-Related Disorders | 1 | 2018 | 460 | 0.120 |
Why?
|
Quinazolines | 1 | 2021 | 1356 | 0.120 |
Why?
|
Temperament | 1 | 2016 | 283 | 0.120 |
Why?
|
Folic Acid | 1 | 2021 | 1300 | 0.120 |
Why?
|
Limbic System | 1 | 2016 | 426 | 0.120 |
Why?
|
Pyridines | 4 | 2018 | 2825 | 0.110 |
Why?
|
Piperidines | 1 | 2021 | 1602 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 35421 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 1 | 2021 | 2038 | 0.100 |
Why?
|
Synaptic Transmission | 1 | 2017 | 1178 | 0.100 |
Why?
|
Prefrontal Cortex | 2 | 2018 | 2147 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9734 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1315 | 0.090 |
Why?
|
Dopamine | 1 | 2017 | 1591 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2219 | 0.090 |
Why?
|
Motor Activity | 1 | 2019 | 2714 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2902 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4409 | 0.080 |
Why?
|
Glioblastoma | 1 | 2021 | 3481 | 0.070 |
Why?
|
Cognition | 1 | 2022 | 6770 | 0.060 |
Why?
|
Humans | 14 | 2024 | 744343 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5535 | 0.060 |
Why?
|
Parietal Lobe | 2 | 2021 | 838 | 0.060 |
Why?
|
Young Adult | 5 | 2022 | 56430 | 0.060 |
Why?
|
Rats, Wistar | 2 | 2018 | 1901 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2017 | 2775 | 0.060 |
Why?
|
Sandhoff Disease | 1 | 2021 | 13 | 0.050 |
Why?
|
Tay-Sachs Disease | 1 | 2021 | 17 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8388 | 0.050 |
Why?
|
Animals | 8 | 2021 | 168757 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2017 | 5708 | 0.050 |
Why?
|
Deoxycholic Acid | 1 | 2020 | 54 | 0.050 |
Why?
|
Amphotericin B | 1 | 2020 | 137 | 0.050 |
Why?
|
Mice | 4 | 2020 | 81183 | 0.050 |
Why?
|
Fluconazole | 1 | 2020 | 146 | 0.050 |
Why?
|
Aging | 1 | 2019 | 8664 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2021 | 8863 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 288 | 0.050 |
Why?
|
Cryptococcus neoformans | 1 | 2020 | 119 | 0.040 |
Why?
|
Horses | 1 | 2021 | 304 | 0.040 |
Why?
|
Diffusion | 1 | 2021 | 833 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1184 | 0.040 |
Why?
|
Adult | 5 | 2024 | 214055 | 0.040 |
Why?
|
Clone Cells | 1 | 2021 | 1692 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.040 |
Why?
|
Moloney murine leukemia virus | 1 | 2017 | 139 | 0.040 |
Why?
|
Self Administration | 1 | 2018 | 385 | 0.040 |
Why?
|
Inverted Repeat Sequences | 1 | 2017 | 61 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2018 | 8037 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2645 | 0.040 |
Why?
|
Base Composition | 1 | 2017 | 293 | 0.040 |
Why?
|
Drug Carriers | 1 | 2021 | 693 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2021 | 2557 | 0.030 |
Why?
|
Aged | 3 | 2024 | 163280 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
Biological Availability | 1 | 2016 | 397 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2018 | 813 | 0.030 |
Why?
|
Pyrrolidines | 1 | 2017 | 342 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13989 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 1959 | 0.030 |
Why?
|
Thermodynamics | 1 | 2017 | 596 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1706 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2018 | 442 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
RNA Stability | 1 | 2017 | 321 | 0.030 |
Why?
|
Cerebellum | 1 | 2021 | 1488 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2017 | 913 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2274 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2021 | 1736 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 2327 | 0.030 |
Why?
|
Benzamides | 1 | 2017 | 1379 | 0.030 |
Why?
|
Rats | 2 | 2018 | 24260 | 0.020 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
Female | 8 | 2021 | 380194 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2017 | 1670 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 828 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5217 | 0.020 |
Why?
|
Alcoholism | 1 | 2018 | 1906 | 0.020 |
Why?
|
Male | 6 | 2021 | 350118 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7149 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15997 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6993 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12797 | 0.020 |
Why?
|
Blood Glucose | 1 | 2018 | 6256 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18029 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13695 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|